Beyond Air, Inc. Finite-Lived Intangible Asset, Expected Amortization, after Year Five
Beyond Air, Inc. (XAIR) had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $197.00 thousand as of 2025-03-31, per its 10-K filed 2025-06-20.
Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2025-06-20
- 2025-03-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $197.00K.
- 2024-03-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $402.00K.
- 2023-03-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $607.00K.
- 2022-03-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $798.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | Finite-Lived Intangible Asset, Expected Amortization, after Year Five as first filed |
|---|---|---|
| 2025-03-31 | $197.00K 10-K · filed 2025-06-20 | |
| 2024-03-31 | $402.00K 10-K · filed 2024-06-24 | |
| 2023-03-31 | $607.00K 10-K · filed 2023-06-22 | |
| 2022-03-31 | $798.00K 10-K · filed 2022-06-29 | |
| 2021-03-31 | $184.00K 10-Q · filed 2022-02-10 | $184.30K 10-K · filed 2021-06-10 |
| 2020-06-30 | $222.38K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $222.38K 10-K · filed 2020-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |